Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Accord Healthcare Limited, Sage House, 319, Pinner Road, North Harrow, Middlesex HA14HF, United Kingdom
Metoprolol Tartrate 100 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White to off-white, approximately 10 mm round, biconvex tablet marked “125 A” on one side and a scoreline on the other side. The tablet can be divided into equal halves. |
Each tablet contains Metoprolol tartrate 100 mg.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Metoprolol |
Metoprolol is a cardioselective beta-adrenergic blocking agent. It has a relatively greater blocking effect on beta1-receptors (ie those mediating adrenergic stimulation of heart rate and contractility and release of free fatty acids from fat stores) than on beta2-receptors, which are chiefly involved in broncho and vasodilation. |
| List of Excipients |
|---|
|
Cellulose, microcrystalline (E460) |
Tablets are packed in PVC/PVdC – Aluminium blisters containing 10, 20, 28, 30, 50, 56, 60, 84 and 90 tablets.
Not all pack sizes may be marketed.
Accord Healthcare Limited, Sage House, 319, Pinner Road, North Harrow, Middlesex HA14HF, United Kingdom
PL 20075/0305
23/09/2011
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
